Quadratus Lumborum Block Reduced Postpartum Uterine Pain After Virginal Childbirth

March 12, 2024 updated by: Chang Gung Memorial Hospital
With the continuous advancement of ultrasonic technology, nerve block in which drugs are injected into the periphery of the target nerve through ultrasonic guidance has become the mainstream method for postoperative pain control. The quadratus lumborum nerve block has been effectively and safely used in abdominal surgery (such as laparotomy, caesarean section, etc.), effectively reducing postoperative wounds and visceral pain. There is no research on the use of quadratus lumborum nerve block to control the pain of natural postpartum uterine contractions in the current literature, so the purpose of this experiment is to explore whether the quadratus lumborum nerve block can effectively reduce the pain of uterine contractions after vaginal delivery.

Study Overview

Study Type

Interventional

Enrollment (Actual)

66

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taoyuan City, Taiwan, 33305
        • Chang Gung Memorial Hospital (Linkou)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Females over twenty years of age
  • Maternal vaginal delivery
  • Postpartum moderate to severe pain with uterine contractions (Numerical Pain Scale (NRS) ≥ 4 points) after delivery.
  • Subject's consent signed by the subject

Exclusion Criteria:

  • Severe coagulation abnormalities (PLT<100000、INR>1.2、PT>13)
  • Infection of the epidermis at the anticipated relevant site of injection
  • Allergy to local anesthetics
  • Allergy to or abuse of pain control medications
  • Episiotomy is more painful than uterine contractions
  • Inability to cooperate with associated pain assessment
  • Body Mass Index (BMI) ≧ 35 kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: quadratus lumborum nerve block group with injection of local anesthetic (Ropivacaine)
The subjects would have quadratus lumborum nerve block group with injection of local anesthetic (Ropivacaine) after vaginal delivery.
Echo guided quadratus lumborum nerve block with ropivacaine
Other Names:
  • QLB
Placebo Comparator: quadratus lumborum nerve block with normal saline
The subjects would have quadratus lumborum nerve block with normal saline after vaginal delivery.
Echo guided quadratus lumborum nerve block with normal saline
Other Names:
  • QLB

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain associated with uterine contractions
Time Frame: Right before intervention
Grading with Numerical Pain Scale [0 (no pain at all) to 10 (worst imaginable pain)] and Visual Analogue Scale [mark a position between 0 (no pain at all) to 10 (worst imaginable pain)]
Right before intervention
Pain associated with uterine contractions
Time Frame: 1 hour after intervention
Grading with Numerical Pain Scale [0 (no pain at all) to 10 (worst imaginable pain)] and Visual Analogue Scale [mark a position between 0 (no pain at all) to 10 (worst imaginable pain)]
1 hour after intervention
Pain associated with uterine contractions
Time Frame: 6 hours after intervention
Grading with Numerical Pain Scale [0 (no pain at all) to 10 (worst imaginable pain)] and Visual Analogue Scale [mark a position between 0 (no pain at all) to 10 (worst imaginable pain)]
6 hours after intervention
Pain associated with uterine contractions
Time Frame: 12 hours after intervention
Grading with Numerical Pain Scale [0 (no pain at all) to 10 (worst imaginable pain)] and Visual Analogue Scale [mark a position between 0 (no pain at all) to 10 (worst imaginable pain)]
12 hours after intervention
Pain associated with uterine contractions
Time Frame: 24 hours after intervention
Grading with Numerical Pain Scale [0 (no pain at all) to 10 (worst imaginable pain)] and Visual Analogue Scale [mark a position between 0 (no pain at all) to 10 (worst imaginable pain)]
24 hours after intervention
Pain associated with uterine contractions
Time Frame: 36 hours after intervention
Grading with Numerical Pain Scale [0 (no pain at all) to 10 (worst imaginable pain)] and Visual Analogue Scale [mark a position between 0 (no pain at all) to 10 (worst imaginable pain)]
36 hours after intervention
Pain associated with uterine contractions
Time Frame: 48 hours after intervention
Grading with Numerical Pain Scale [0 (no pain at all) to 10 (worst imaginable pain)] and Visual Analogue Scale [mark a position between 0 (no pain at all) to 10 (worst imaginable pain)]
48 hours after intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Edinburgh Postnatal Depression Scale
Time Frame: Right before intervention
Edinburgh Postnatal Depression Scale 10-item (ranging from 0 to 30, possible depression > 10)
Right before intervention
Pittsburgh sleep quality index
Time Frame: Right before intervention
Pittsburgh sleep quality index (ranging from 0 to 21, where lower scores denote a healthier sleep quality)
Right before intervention
Modified Fatigue Symptoms Checklist
Time Frame: Right before intervention
Modified Fatigue Symptoms Checklist (ranging from 0 to 40, where higher scores mean more exhausted physical and mental status)
Right before intervention
Postpartum Perceived Stress Scale
Time Frame: Right before intervention
Postpartum Perceived Stress Scale - 14 items (range from 0 to 70 with higher scores indicating higher perceived stress)
Right before intervention
Edinburgh Postnatal Depression Scale
Time Frame: 48 hours after intervention
Edinburgh Postnatal Depression Scale 10-item (from 0 to 30, possible depression > 10)
48 hours after intervention
Pittsburgh sleep quality index
Time Frame: 48 hours after intervention
Pittsburgh sleep quality index Modified Fatigue Symptoms Checklis (ranging from 0 to 21, where lower scores denote a healthier sleep quality)
48 hours after intervention
Modified Fatigue Symptoms Checklist
Time Frame: 48 hours after intervention
Modified Fatigue Symptoms Checklist (ranging from 0 to 40, where higher scores mean more exhausted physical and mental status)
48 hours after intervention
Postpartum Perceived Stress Scale
Time Frame: 48 hours after intervention
Postpartum Perceived Stress Scale - 14 items (range from 0 to 70 with higher scores indicating higher perceived stress)
48 hours after intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 12, 2022

Primary Completion (Actual)

August 31, 2022

Study Completion (Actual)

August 31, 2022

Study Registration Dates

First Submitted

April 5, 2022

First Submitted That Met QC Criteria

May 11, 2022

First Posted (Actual)

May 12, 2022

Study Record Updates

Last Update Posted (Actual)

March 15, 2024

Last Update Submitted That Met QC Criteria

March 12, 2024

Last Verified

February 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Vaginal Delivery

Clinical Trials on quadratus lumborum nerve block (ropivacaine )

Subscribe